TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
59,086
|
43,550
|
34,807 |
| Financial expenses |
2
|
14
|
6 |
| Earnings before taxes |
3,136
|
-4,862
|
236 |
| EBITDA |
4,096
|
-3,756
|
3,108 |
| Total assets |
40,881
|
34,187
|
38,064 |
| Current assets |
33,736
|
26,758
|
31,295 |
| Current liabilities |
11,267
|
8,181
|
9,243 |
| Equity capital |
29,515
|
25,911
|
28,734 |
| - share capital |
26,013
|
25,554
|
23,860 |
| Employees (average) |
21
|
23
|
20 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
72.2%
|
75.8%
|
75.5% |
| Turnover per employee |
2,814
|
1,893
|
1,740 |
| Profit as a percentage of turnover |
5.3%
|
-11.2%
|
0.7% |
| Return on assets (ROA) |
7.7%
|
-14.2%
|
0.6% |
| Current ratio |
299.4%
|
327.1%
|
338.6% |
| Return on equity (ROE) |
10.6%
|
-18.8%
|
0.8% |
| Change turnover |
14,751
|
6,274
|
13,148 |
| Change turnover % |
33%
|
17%
|
61% |
| Chg. No. of employees |
-2
|
3
|
4 |
| Chg. No. of employees % |
-9%
|
15%
|
25% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.